SCHEMBL28385019

SCHEMBL28385019

CS(=O)(=O)c1ccc(Sc2ccc(S(C)(=O)=O)cc2N)c(N)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PD P11413 1/20 0.61
IDE P14735 1/20 0.61
ALDH1A1 P00352 3/20 0.53
HSD17B10 Q99714 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
HPGD P15428 1/20 0.53
CYP2C19 P33261 1/20 0.53
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.39
ENPP2 Q13822 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
SLC6A2 P23975 3/20 0.37
SLC6A4 P31645 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28867147 0.86 G6PD (0.47) G6PDIDEALDH1A1HSD17B10CYP1A2
SCHEMBL898422 0.79 G6PD (0.64) G6PDIDEALDH1A1HSD17B10CYP1A2
SCHEMBL634380 0.78 GAA (0.70) G6PDIDEALDH1A1HSD17B10CYP1A2
SCHEMBL1368132 0.75 G6PD (0.55) G6PDIDEALDH1A1GAAMAPT
SCHEMBL9538632 0.74 G6PD (0.58) G6PDIDEALDH1A1CA12CA1
SCHEMBL1371008 0.73 G6PD (0.53) G6PDIDEALDH1A1CA12CA1
SCHEMBL11820341 0.73 G6PD (0.53) G6PDIDEALDH1A1HSD17B10CYP1A2
SCHEMBL1370002 0.73 LMNA (0.55) G6PDIDEALDH1A1MAPTCA12
SCHEMBL1371001 0.73 G6PD (0.53) G6PDIDEGAAMAPTCA12
SCHEMBL1006804 0.73 G6PD (0.53) G6PDIDEALDH1A1HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111039898-B Preparation method of metopimazine intermediate 暨明医药科技(苏州)有限公司 2021-12-24 CN disclosed
CN-111039898-A Preparation method of metopimazine intermediate 暨明医药科技(苏州)有限公司 2020-04-21 CN disclosed